ANDREA RICHARDSON: Open Payments
NPI 1023575453 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,026 in 33 payments from 16 companies in 2025. Trend: 2023 $530 · 2024 $1,141 · 2025 $1,026
Food & beverage: $1,026
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 3 | $170 |
| E.R. Squibb & Sons, L.L.C. | 2 | $130 |
| United Therapeutics Corporation | 2 | $129 |
| SCPHARMACEUTICALS INC. | 1 | $125 |
| Novartis Pharmaceuticals Corporation | 5 | $90 |
| Merck Sharp & Dohme LLC | 4 | $79 |
| Actelion Pharmaceuticals US, Inc. | 2 | $59 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| Alnylam Pharmaceuticals Inc. | 2 | $34 |
Products named: Barostim Neo System, CAMZYOS, FUROSCIX, LEQVIO, VERQUVO, LifeVest, JARDIANCE, OPSYNVI.
Industry payments across FL — which companies pay providers there.
